Novo Nordisk’s “Bait-and-Switch” Super Bowl Diabetes Marketing
Novo Nordisk's diabetes drug marketers are hitching on to the Super Bowl bandwagon. This morning, for example, I received an e-mail from Novo Nordisk's...
Pharma Marketing News Vol. 12, No. 1: 31 January 2013
Welcome to Volume 12, Issue #1 (31 Januray 2013) of Pharma Marketing News.
Pharma Marketing News Vol. 12, No. 1: 31 January 2013
Welcome to Volume 12, Issue #1 (31 Januray 2013) of Pharma Marketing News.
Pharma Needs to Step Up & Help Develop a Universal Flu Vaccine
Recently, I've been reading a lot about a "universal flu vaccine." A Bloomberg View piece, for example, points out that the greatest breakthrough in...
In a Pre-emptive Strike, Amgen & Genentech (Roche) Lobby States to Block Biosimilars
No doubt you've heard of how Amgen essentially paid off U.S. Senators to sneak a provision in the "fiscal cliff" bill that delays price...
Lipitor & Plavix: The Last of the Small Molecule Best Sellers?
Forbes just published a list of "Best Selling Drugs of All Time" (see here). I created the following chart from the data cited (click...
Will Novo Air a Super Bowl Commercial?
Yesterday, on my way to the NJ Turnpike, I passed by the BMS R&D facilities in Hopewell, NJ and noticed a sign announcing that...
An Attempt to Exhume the “Ethical Drug Industry”
When was the last time you heard "ethical" and "drug industry" in the same sentence? These days, you are more likely to see "unethical"...
Is Pharma Too Big to Succeed?
You've heard of investment banks being "Too Big To Fail" as an excuse for government intervention. After reading the book "Devalued and Distrusted" by...
Drop TV Ads, Says John LaMattina, Former Pfizer President of R&D
It's been a long, long time since anyone has seriously suggested a "moratorium" or complete halt to direct-to-consmer (DTC) drug TV advertising in the...
